Cavelti-Weder, C., Timper, K., Seelig, E., Keller, C., Osranek, M., Lässing, U., . . . Bachmann, M. F. (2016). Development of an Interleukin-1β Vaccine in Patients with Type 2 Diabetes. Molecular Therapy, 24(5), 1003-1012. https://doi.org/10.1038/mt.2015.227
Chicago Style (17th ed.) CitationCavelti-Weder, Claudia, et al. "Development of an Interleukin-1β Vaccine in Patients with Type 2 Diabetes." Molecular Therapy 24, no. 5 (2016): 1003-1012. https://doi.org/10.1038/mt.2015.227.
MLA (8th ed.) CitationCavelti-Weder, Claudia, et al. "Development of an Interleukin-1β Vaccine in Patients with Type 2 Diabetes." Molecular Therapy, vol. 24, no. 5, 2016, pp. 1003-1012, https://doi.org/10.1038/mt.2015.227.
Warning: These citations may not always be 100% accurate.
Visit our Citation Styles guide for help on properly citing sources.
Visit our Citation Styles guide for help on properly citing sources.